Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. (Q51746108)

11 April 2018

title

Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. (English)

1 reference

11 April 2018

0 references

J Zhang

1

1 reference

11 April 2018

Y Tokui

2

1 reference

11 April 2018

K Yamagata

3

1 reference

11 April 2018

J Kozawa

4

1 reference

11 April 2018

K Sayama

5

1 reference

11 April 2018

H Iwahashi

6

1 reference

11 April 2018

K Okita

7

1 reference

11 April 2018

M Miuchi

8

1 reference

11 April 2018

H Konya

9

1 reference

11 April 2018

T Hamaguchi

10

1 reference

11 April 2018

M Namba

11

1 reference

11 April 2018

I Shimomura

12

1 reference

11 April 2018

J-I Miyagawa

13

1 reference

11 April 2018

publication date

14 July 2007

1 reference

11 April 2018

published in

Diabetologia

1 reference

11 April 2018

volume

50

1 reference

11 April 2018

issue

9

1 reference

11 April 2018

page(s)

1900-1909

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-007-0737-6

exact match

0 references

cites work

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

12 December 2020

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.

1 reference

12 December 2020

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

1 reference

12 December 2020

Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.

1 reference

12 December 2020

Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic

1 reference

12 December 2020

Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells

1 reference

12 December 2020

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

12 December 2020

beta-cell apoptosis: stimuli and signaling

1 reference

12 December 2020

Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats

1 reference

12 December 2020

Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.

1 reference

12 December 2020

Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse

1 reference

12 December 2020

The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth

1 reference

12 December 2020

Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

1 reference

12 December 2020

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.

1 reference

12 December 2020

Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion

1 reference

12 December 2020

Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide

1 reference

12 December 2020

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

12 December 2020

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

1 reference

12 December 2020

The glucagon-like peptides

1 reference

12 December 2020

Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.

1 reference

12 December 2020

Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes

1 reference

12 December 2020

Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice.

1 reference

12 December 2020

cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells

1 reference

12 December 2020

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

1 reference

12 December 2020

Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes

1 reference

12 December 2020

Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system

1 reference

12 December 2020

Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures

1 reference

12 December 2020

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats

1 reference

12 December 2020

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

12 December 2020

GLP-1 inhibition of pancreatic islet cell apoptosis.

1 reference

12 December 2020

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

1 reference

12 December 2020

GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans

1 reference

12 December 2020

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

12 December 2020

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

12 December 2020

Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells

1 reference

12 December 2020

Beta cell apoptosis in T cell-mediated autoimmune diabetes

1 reference

12 December 2020

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

1 reference

12 December 2020

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.

1 reference

12 December 2020

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

1 reference

12 December 2020

10.1007/S00125-007-0737-6

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

17632702

1 reference

11 April 2018